“an increasing trend”

1 G, P < 0.05), whereas NEFA showed an increasing trend (Fig. 1 F, P = 0.055).

Organ indices, including those of the spleen, thymus, liver, heart, and brain, did not differ significantly between the groups, although the MLCT + 2′-FL group showed an increasing trend in spleen index compared to the CON group (4.05 vs. 3.26, p = 0.055) ( Figure 1 D). 3.2.

However, an increasing trend in HDL levels ( p = 0.055) was identified with including OC in the diet, which may indicate a beneficial effect on lipid metabolism.

However, in TNFα perfused hearts, CV L alone increased over time with no change in CV T as seen in representative isochrones (Figure 2A ) and summary data (Figure 2B ), and as a result an increasing trend in AR was also observed ( p = 0.055, Figure 2B ).

Compared with Oral-CON group, microbiota from HBW chickens significantly reduced the relative mRNA expression of zinc transporter 1 ( P -value < 0.01) but markedly increased the mRNA expression of glucose transporter type 1 ( P -value < 0.05), and an increasing trend was observed for the expression of taste receptor family 1 member 3 ( P -value = 0.055; Fig. 5G ).

In addition, the risk of DVT in genetically predicted IBD patients had an increasing trend with marginal statistical effect in the IVW analysis (OR = 1.032, 95% CI: 0.999-1.066, p = 0.055) ( Figure 2A ).

The population of CD4 + /CD3 + T cells in the healthy or EAM groups, showed an increasing trend, and increased in QQMNCs compared to PBMNCs (healthy control, 1.10-fold in CD4 + /CD3 + cells, p = 0.055; EAM, 1.45-fold in CD4 + /CD3 + cells, p = 0.015).

Finally we observed an increasing trend for the biomarker of protein age, D-Serine ( P = 0.055).

Notably, the relative abundance of Firmicutes in the lycopene group showed an increasing trend compared to the PC group ( p = 0.055), whereas the relative abundance of Bacteroidota exhibited a decreasing trend relative to the PC group ( p = 0.059).

In addition, we identified an increasing trend in sera neutralizing activity against Omicron BA.1 over time (p = 0.055, Conover-Iman test) (Fig. 6f ).

No significant differences were observed regarding cytokines IL-6 ( Figure 7C ), IL-12p70 ( Figure 7D ) or IL-10 ( Figure 7E ), despite an increasing trend for IL-12p70 ( p < 0.055).

With respect to target identification rates for the 7–13 condition, the correlation between b and the ELS for the practiced positions showed an increasing trend that peaked at the 3-Day condition, r (11) = 0.54, p = 0.055.

IL-7/IL-7R system Arm A displayed an increasing trend in CD127+CD4+ T-cells, close to statistical significance at w12 (T0, 69 [54.9-82.3]%, w12, 74.2 [58.1-82.8]%, w48 80.9 [63.2-89.3]%; p=.055 for T0 vs w12; p=.46 for T0 vs w48), whereas no changes was shown over time in arm B (T0, 59.2 [41.2-81.1], w12, 65.5 [52.4-70.4]%, w48, 80.7 [62.3-83.4]%, p=.39 for T0 vs w12, p=.16 forT0 vs w48) ( Figure 5A ).

While age showed an increasing trend across groups, this did not reach statistical significance ( p = 0.055).

In addition, cGMP showed an increasing trend (1.42-fold, P = 0.055) ( Figure 3A ).

We observed an increasing trend of RAGE immunoreactivity area at two and six months of diabetes when compared with controls ( P = 0.0551, P = 0.0527, respectively; Fig. 3 E, G).

However, PSA displayed an increasing trend in median values from early to advanced stage ( p = 0.05528), consistent with its known association with tumor burden.

At the genus level, specialist genus Akkermansia showed an increasing trend in the placebo group from month 3 to 6 ( p = 0.0556) and a higher abundance in the placebo group at month 6 ( p = 0.0649, Figure 5D-E ).

An increasing trend, even if not significant, of IL-10, was found (165.0 ± 5.83, p = 0.056) in the spinal cord of mice receiving the lebecetin (0.32 nmol) into the hind paw.

Results In the single-dose group, the CTG exhibited a significant increase in the RBC MTX Cmax compared to the MTG (P = 0.023), whereas the AUC of RBC MTX showed an increasing trend (P = 0.056).

5a ) and this group difference showed an increasing trend over time, β = 0.02, t(26) = 2.00, p = 0.056.

One study reported an increasing trend in the percentage of infants admitted with temperature in the normothermic range post-intervention (54.8% vs. 71.3%; p = 0.056) [ 21 ].

A similar result was observed in the ELISA test, in which an increasing trend of the IL-10 level in the MI group compared to the control group ( P = 0.056) and the TNF-α level in the MI + SnMP group compared to the MI group ( P > 0.05) was observed, although insignificant.

In addition, an increasing trend towards the expression levels of MAML3 was observed in sAML ( p = 0.056) (Fig. 4 C).

Compared with GG genotype carriers, CC genotype carriers showed an increasing trend in BMI (31.1 ± 8.2 vs. 34.6 ± 9.0, P = 0.056; Fig. 1m ), as well as in HOMA-IR (6.3 ± 5.4 vs. 8.6 ± 8.0, P = 0.108; Fig. 1n ).